Differentiating Anti-NMDA receptor encephalitis from other diseases

Anti-NMDA receptor encephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Anti-NMDA receptor encephalitis from Other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Differentiating Anti-NMDA receptor encephalitis from other diseases On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Differentiating Anti-NMDA receptor encephalitis from other diseases All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Differentiating Anti-NMDA receptor encephalitis from other diseases
CDC on Differentiating Anti-NMDA receptor encephalitis from other diseases
Differentiating Anti-NMDA receptor encephalitis from other diseases in the news
Blogs on Differentiating Anti-NMDA receptor encephalitis from other diseases
Directions to Hospitals Treating Anti-NMDA receptor encephalitis
Risk calculators and risk factors for Differentiating Anti-NMDA receptor encephalitis from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;AE Dheeraj Makkar, M.D.[2]

Differentiating Anti-NMDA Receptor Encephalitis from other Diseases

Antigen	NMDA receptor NR1	Lgil	CASPR2	AMPA receptor	GABA B receptor	Glycine receptor	MgluR5
Age(median)/gender female : male	0·6–85 (21) 4:1	30–80 (60) 1:2
row 2, cell 1	row 2, cell 2	row 2, cell 3